The Role Played by Novel Inflammatory Markers in Assessment of Peripheral Artery Disease.

: Atherosclerosis is a multifactorial process in which inflammatory markers have both therapeutic and prognostic roles. Recent studies bring into question the importance of assessing new inflammatory markers in relation to the severity of peripheral artery disease (PAD), such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-C-reactive protein ratio (LCR). : We conducted a retrospective and descriptive study including 652 patients with PAD, who were divided into two groups according to the severity of the ankle-brachial index value: mild and moderate obstruction (257 patients) and severe obstruction (395 patients). We evaluated demographics, anthropometric data and clinical and paraclinical parameters in relation to the novel inflammatory biomarkers mentioned above. : Weight ( = 0.048), smoking ( = 0.033), the number of cardiovascular risk factors ( = 0.041), NLR ( = 0.037), LCR ( = 0.041) and PLR ( = 0.019), the presence of gangrene ( = 0.001) and the number of lesions detected via peripheral angiography ( < 0.001) were statistically significant parameters in our study. For the group of patients with severe obstruction, all three inflammatory biomarkers were statistically significantly correlated with a serum low-density lipoprotein-cholesterol level, the number of cardiovascular risk factors, rest pain, gangrene and a risk of amputation. In addition, directly proportional relationships were found between NLR, PLR and the number of stenotic lesions ( = 0.018, = 0.016). Also, NLR (area under the curve = 0.682, = 0.010) and PLR (AUC = 0.692, = 0.006) were predictors associated with a high risk of amputation in patients with an ABI < 0.5. : in our study, we demonstrated the importance of assessing inflammatory markers in relation to the presence of cardiovascular risk factors through the therapeutic and prognostic value demonstrated in PAD.